Literature DB >> 3972276

Role of plasmapheresis in primary biliary cirrhosis.

L B Cohen, E P Ambinder, A M Wolke, S P Field, F Schaffner.   

Abstract

Five patients with primary biliary cirrhosis and prolonged cholestasis underwent intensive plasmapheresis. The indications for plasmapheresis included intractable pruritus or hypercholesterolemia and xanthomatous neuropathy. Patients noted a rapid improvement of pruritus and fatigue which was sustained as long as plasmapheresis was continued. Cholesterol levels were lowered an average of 10.3 mmol/l and xanthomata were reduced in three of four patients. Two patients with painful neuropathy caused by xanthomata experienced relief of this symptom. The liver and spleen size were not affected by plasmapheresis, and activities of aminotransferases, alkaline phosphatase and titres of mitochondrial antibody remained unchanged. We conclude that plasmapheresis has a role in the therapeutic management of patients with advanced primary biliary cirrhosis who are disabled by the complications of pruritus, xanthomatous neuropathy, or hypercholesterolemia with xanthoma formation.

Entities:  

Mesh:

Year:  1985        PMID: 3972276      PMCID: PMC1432633          DOI: 10.1136/gut.26.3.291

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  13 in total

1.  THE LONG TERM USE OF CHOLESTYRAMINE IN THE TREATMENT OF PRIMARY BILIARY CIRRHOSIS.

Authors:  F SCHAFFNER; F M KLION; A J LATUFF
Journal:  Gastroenterology       Date:  1965-03       Impact factor: 22.682

2.  Xanthomatous neuropathy in primary biliary cirrhosis.

Authors:  P K Thomas; J G Walker
Journal:  Brain       Date:  1965-12       Impact factor: 13.501

3.  Plasma exchange for hypercholesterolaemia.

Authors:  G R Thompson
Journal:  Lancet       Date:  1981-06-06       Impact factor: 79.321

4.  Rheumatic disorders in primary biliary cirrhosis.

Authors:  A K Clarke; R M Galbraith; E B Hamilton; R Williams
Journal:  Ann Rheum Dis       Date:  1978-02       Impact factor: 19.103

Review 5.  Clinical-pathologic relations in primary biliary cirrhosis.

Authors:  F Schaffner; H Popper
Journal:  Prog Liver Dis       Date:  1982

6.  Plasma exchange in primary biliary cirrhosis.

Authors:  P W Keeling; J Bull; P Kingston; R P Thompson
Journal:  Postgrad Med J       Date:  1981-07       Impact factor: 2.401

7.  Circulating immune complexes and complement activation in primary biliary cirrhosis.

Authors:  J R Wands; J L Dienstag; A K Bhan; E R Feller; K J Isselbacher
Journal:  N Engl J Med       Date:  1978-02-02       Impact factor: 91.245

8.  Complications of therapeutic apheresis, including a fatal case with pulmonary vascular occlusion.

Authors:  M D Rubenstein; R T Wall; G S Wood; M A Edwards
Journal:  Am J Med       Date:  1983-07       Impact factor: 4.965

9.  Treatment of pruritus of cholestasis by plasma perfusion through USP-charcoal-coated glass beads.

Authors:  B H Lauterburg; H F Taswell; A A Pineda; E R Dickson; E A Burgstaler; G L Carlson
Journal:  Lancet       Date:  1980-07-12       Impact factor: 79.321

10.  Is primary biliary cirrhosis an immune complex disease?

Authors:  H C Thomas; B J Potter; S Sherlock
Journal:  Lancet       Date:  1977-12-17       Impact factor: 79.321

View more
  16 in total

1.  Successfully treated intractable pruritus with rifampin in a case of benign recurrent intrahepatic cholestasis.

Authors:  Teru Kumagi; E Jenny Heathcote
Journal:  Clin J Gastroenterol       Date:  2008-09-26

Review 2.  Treatment in primary biliary cirrhosis.

Authors:  N D Finlayson
Journal:  Br Med J (Clin Res Ed)       Date:  1987-10-10

Review 3.  Primary biliary cirrhosis: new perspectives.

Authors:  W C Maddrey
Journal:  Trans Am Clin Climatol Assoc       Date:  1989

Review 4.  Pruritus associated with cholestasis. A review of pathogenesis and management.

Authors:  M Khandelwal; P F Malet
Journal:  Dig Dis Sci       Date:  1994-01       Impact factor: 3.199

5.  Charcoal hemoperfusion in the treatment of medically refractory pruritus in cholestatic liver disease.

Authors:  Wonngarm Kittanamongkolchai; Ziad M El-Zoghby; J Eileen Hay; Russell H Wiesner; Patrick S Kamath; Nicholas F LaRusso; Kymberly D Watt; Carl H Cramer; Nelson Leung
Journal:  Hepatol Int       Date:  2016-12-08       Impact factor: 6.047

6.  Effect of oral naltrexone on pruritus in cholestatic patients.

Authors:  Fariborz Mansour-Ghanaei; Amir Taheri; Hossein Froutan; Hadi Ghofrani; Mohsen Nasiri-Toosi; Amir-Hossein Bagherzadeh; Mohammad-Jafar Farahvash; Shahram Mirmomen; Naser Ebrahimi-Dariani; Elham Farhangi; Zahra Pourrasouli
Journal:  World J Gastroenterol       Date:  2006-02-21       Impact factor: 5.742

Review 7.  Pruritus in chronic liver disease: mechanisms and treatment.

Authors:  Nora V Bergasa
Journal:  Curr Gastroenterol Rep       Date:  2004-02

8.  Role of plasmapheresis in the treatment of severe pruritus in pregnant patients with primary biliary cirrhosis: case reports.

Authors:  Alallam Alallam; David Barth; E Jenny Heathcote
Journal:  Can J Gastroenterol       Date:  2008-05       Impact factor: 3.522

Review 9.  Pathogenesis and treatment of pruritus in cholestasis.

Authors:  Andreas E Kremer; Ulrich Beuers; Ronald P J Oude-Elferink; Thomas Pusl
Journal:  Drugs       Date:  2008       Impact factor: 9.546

10.  Albumin liver dialysis as pregnancy-saving procedure in cholestatic liver disease and intractable pruritus.

Authors:  Maud Lemoine; Aurelie Revaux; Claire Francoz; Guillaume Ducarme; Sabine Brechignac; Emmanuel Jacquemin; Michele Uzan; Nathalie Ganne-Carrie
Journal:  World J Gastroenterol       Date:  2008-11-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.